Type 2 diabetes in young people ages 10 to19 has more than doubled in the past 20 years, yet it remains difficult for physicians to predict who will be diagnosed and who will improve with treatment. A newly published study from the University of Oklahoma shows that measuring the circulating abundance of microRNAs – which affect insulin-producing beta cells in the pancreas – is likely as effective as measuring the level of sugar in the blood for determining how a young person with the condition will fare.
Paxlovid is not fully accessible to those who need it most: the immunocompromised
The pandemic is over for most of the world. But for the 2.7% of adults in the United States who are immunocompromised, it isn’t. I’m
September 27, 2023